Men are less likely than women to survive some cancers: study
30 October, 2018A population-based study has that found men have a survival disadvantage relative to women for 11 of 25 cancer types investigated.
Map of human liver cells reveals molecular make-up of individual cells
25 October, 2018A map of the cells in the human liver reveals the differences between individual cells at the molecular level which can have a profound impact on their behaviour in tissue, tumours and disease.
Discovery could make therapeutic insulins more effective
25 October, 2018A discovery co-led by Australian researchers could make therapeutic insulins more effective by better mimicking the way insulin works in the body.
Biochemical engineering 'hack' could lead to new drugs
24 October, 2018A biochemical engineering 'hack' could lead to new drugs, flavours, fragrances and biofuels.
Macrogen opens office in Australia
24 October, 2018South Korean biotech company Macrogen has opened an office in NSW.
Using artificial intelligence to measure breast density
18 October, 2018An artificial intelligence (AI) algorithm measures breast density at the level of an experienced mammographer.
The role of Pax5 in maintaining immune health
17 October, 2018A protein called Pax5 helps to efficiently organise the genetic information required for immune cells to maintain their form and function and help fight disease.
New urine test detects antibiotic-resistant superbugs
17 October, 2018A new test, called DETECT, spots the molecular signatures of antibiotic-resistant bacteria directly in urine samples.
Vitamin D claimed to have no impact on bone health
12 October, 2018The results of new meta-analysis suggest that vitamin D supplementation does not improve bone mineral density in adults or prevent fractures and falls.
A single embryo, a multiple pregnancy: IVF mystery solved
09 October, 2018Why do some women who undergo assisted reproduction treatment become pregnant with twins or triplets — even when single embryo transfer is performed?
QUE Oncology launches Phase II trials
04 October, 2018QUE Oncology has launched Phase II trials which will see its novel non-hormonal therapy, for women with breast cancer suffering hot flushes and night sweats, tested at six sites across Australia.
Atmo Biosciences to commercialise gas-sensing capsule
03 October, 2018RMIT University and Atmo Biosciences have signed an agreement that could see an electronic gas-sensing capsule commercially available within four years.
International guideline produced for polycystic ovary syndrome
03 October, 2018The PCOS guideline aims to accelerate the delivery of consistent, evidence-based care across Australia.
Discovery enables more targeted treatment for ovarian cancer
02 October, 2018Scientists have revealed a better way to identify which ovarian cancer patients should respond to powerful drugs called PARP inhibitors.
More than half the world to miss chronic disease targets
26 September, 2018The majority of countries are unlikely to reach the UN's 2030 target to reduce deaths caused by the four major non-communicable diseases in people aged 30–70 years by a third.